Back to Search
Start Over
Cellular mechanisms of IL-17-induced blood-brain barrier disruption.
- Source :
-
FASEB journal : official publication of the Federation of American Societies for Experimental Biology [FASEB J] 2010 Apr; Vol. 24 (4), pp. 1023-34. Date of Electronic Publication: 2009 Nov 25. - Publication Year :
- 2010
-
Abstract
- Recently T-helper 17 (Th17) cells were demonstrated to disrupt the blood-brain barrier (BBB) by the action of IL-17A. The aim of the present study was to examine the mechanisms that underlie IL-17A-induced BBB breakdown. Barrier integrity was analyzed in the murine brain endothelial cell line bEnd.3 by measuring the electrical resistance values using electrical call impedance sensing technology. Furthermore, in-cell Western blots, fluorescence imaging, and monocyte adhesion and transendothelial migration assays were performed. Experimental autoimmune encephalomyelitis (EAE) was induced in C57BL/6 mice. IL-17A induced NADPH oxidase- or xanthine oxidase-dependent reactive oxygen species (ROS) production. The resulting oxidative stress activated the endothelial contractile machinery, which was accompanied by a down-regulation of the tight junction molecule occludin. Blocking either ROS formation or myosin light chain phosphorylation or applying IL-17A-neutralizing antibodies prevented IL-17A-induced BBB disruption. Treatment of mice with EAE using ML-7, an inhibitor of the myosin light chain kinase, resulted in less BBB disruption at the spinal cord and less infiltration of lymphocytes via the BBB and subsequently reduced the clinical characteristics of EAE. These observations indicate that IL-17A accounts for a crucial step in the development of EAE by impairing the integrity of the BBB, involving augmented production of ROS.-Huppert, J., Closhen, D., Croxford, A., White, R., Kulig, P., Pietrowski, E., Bechmann, I., Becher, B., Luhmann, H. J., Waisman, A., Kuhlmann, C. R. W. Cellular mechanisms of IL-17-induced blood-brain barrier disruption.
- Subjects :
- Animals
Antibodies, Neutralizing immunology
Antibodies, Neutralizing pharmacology
Azepines pharmacology
Blood-Brain Barrier immunology
Blood-Brain Barrier pathology
Cell Line, Transformed
Down-Regulation drug effects
Down-Regulation immunology
Encephalomyelitis, Autoimmune, Experimental immunology
Encephalomyelitis, Autoimmune, Experimental pathology
Endothelial Cells immunology
Endothelial Cells pathology
Enzyme Inhibitors pharmacology
Interleukin-17 antagonists & inhibitors
Interleukin-17 immunology
Interleukin-17 pharmacology
Membrane Proteins immunology
Membrane Proteins metabolism
Mice
Mice, Inbred BALB C
Myosin-Light-Chain Kinase
NADPH Oxidases immunology
NADPH Oxidases metabolism
Naphthalenes pharmacology
Occludin
Oxidative Stress drug effects
Oxidative Stress immunology
Reactive Oxygen Species immunology
T-Lymphocytes, Helper-Inducer immunology
T-Lymphocytes, Helper-Inducer pathology
Xanthine Oxidase immunology
Xanthine Oxidase metabolism
Blood-Brain Barrier metabolism
Encephalomyelitis, Autoimmune, Experimental metabolism
Endothelial Cells metabolism
Interleukin-17 metabolism
Reactive Oxygen Species metabolism
T-Lymphocytes, Helper-Inducer metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1530-6860
- Volume :
- 24
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- FASEB journal : official publication of the Federation of American Societies for Experimental Biology
- Publication Type :
- Academic Journal
- Accession number :
- 19940258
- Full Text :
- https://doi.org/10.1096/fj.09-141978